1 / 10

2009 H1N1 Vaccine Program Planning and Implementation

2009 H1N1 Vaccine Program Planning and Implementation. Jay C. Butler MD Director, H1N1 Vaccine Task Force Centers for Disease Control and Prevention July 27, 2009. The Situation We Are Facing Is Not Necessarily The Situation We Planned For. Illness not as severe as 1918 scenario

camdyn
Download Presentation

2009 H1N1 Vaccine Program Planning and Implementation

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. 2009 H1N1 Vaccine Program Planning and Implementation Jay C. Butler MD Director, H1N1 Vaccine Task Force Centers for Disease Control and Prevention July 27, 2009

  2. The Situation We Are Facing Is Not Necessarily The Situation We Planned For • Illness not as severe as 1918 scenario • Epidemiology of disease a bit different • Disease began in the North America • ? Larger amounts of vaccine available than in planning scenarios • ? Confluence of seasonal and pandemic vaccination in Fall 2009

  3. H5N1 or “severe pandemic” Seasonal Influenza A 2009 H1N1 Vaccine Program Will Not Be The Same As A Program For…

  4. Preparedness for 2009 H1N1 Vaccination Program • Implementation planning has started • Data to support future decisions • Southern Hemisphere epidemiologic and virologic data • Clinical trial results on immune responses and reactogenicity • Ongoing analyses of novel H1N1 epidemiology and virology in US

  5. Planning Scenarios • Base Assumptions • Severity of illness remains the same • Risk groups remain the same • Unadjuvanted vaccine is immunogenic and safe • No major antigenic changes in novel H1N1

  6. Planning Scenarios From Current Epidemiology and Base Assumptions • Children and staff in childcare centers and schools (K-12) • Pregnant women, young children, household contact of children <6 months of age • Persons with underlying medical conditions • Health care workers • When enough vaccine available: everyone

  7. CDC H1N1 Vaccine Task Force • Implementation and Distribution • Uptake and Coverage • Safety Monitoring • Effectiveness • Communications

  8. ASTHO NACCHO CSTE AIM Preparedness Program Directors NVPO BARDA CDC Vaccine Implementation Steering Committee And others!

  9. Uncertainties • Vaccine: amount and timing of availability • Formulation (adjuvant?) • Specific recommendations for vaccine use (ACIP meeting July 29) • Timing of availability of H1N1 and seasonal vaccines • Demand for vaccine

More Related